Home Meetings Online CME/CE Clinical Resources EHR/EMR

Regional Conference New York City, NY

Location: New York, NY
Date: November 21-23, 2013

Meeting Overview

Venue:
Jacob K. Javits Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

New York 2014 | New! Online and In-Person programs
May 9, 2014 & May 28, 2014
Learn More »

Explore the online library of activities and earn CME credits today:
Earn CME Credits Online »


CME created with you in mind

Now more than ever, clinicians are challenged by their expanded roles, their limited time, and the need to provide patient care across an ever-broadening array of disease and comorbid conditions.

This complimentary three-day CME program, was developed to meet your needs as a clinician on the front lines of care.

The curriculum for this unique multi-day educational conference covers topics including new avenues in insulin therapy, breakthroughs in new treatment options for obese patients, and clarification of the confusion about COPD. You will acquire up-to-date clinical knowledge that is easily translated into practice, completely free of charge.

View the session schedule»

Get the most value for your time 

  • Attend over 10 cutting-edge sessions—for free!
  • Earn up to 13.5 AMA PRA Category 1 Credits™ or 13.5 AANP contact hours of continuing education.
  • Participate in a SAFE Opioid Prescribing certification series.
  • Learn from expert faculty and have your questions answered. during the Q&A portion of each CME session.
  • Network with your colleagues.


Need another reason to attend?

Keep your brain energized.

A continuation of one of last year’s favorites, the Medical Brain Game—SAFE Opioid Prescribing Edition session presents clinical guidelines in a trivia-style, friendly competition with your peers. You might even win a prize.

View the national conference schedule »

*Primary Care Updates activities are sponsored by pmiCME and produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Presentation Theaters and the Product Forum are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

†Earn up to an additional 9.25 AMA PRA Category 1 Credits™ on
November 23, 2013, at Primary Care Updates and Integrated Approaches to Cardiometabolic Care; seating is extremely limited for these two programs.

Comprehensive CME Program
Pri-Med doctor

Primary Care Updates*
November 21, 2013
A multi-track day of CME programs to supplement your education.

Regional Conference
November 22, 2013
CME curriculum developed in collaboration with the American College of Physicians (ACP), covering the latest topics in primary care medicine ACP logo

Primary Care Updates*
November 23, 2013 | Morning
CME sessions that focus on cardiometabolic disease-specific treatment and management approaches. Seating is extremely limited.

Integrated Approaches to Cardiometabolic Care
November 23, 2013 | Afternoon
Innovative new CME sessions for PCPs, cardiologists, and endocrinologists who jointly manage patients with complex cardiometabolic conditions. Case studies, lectures, and a panel discussion will cover treatment decisions for high-risk patients.


Industry-Sponsored Opportunities

Presentation Theaters**
Get an in-depth look at the latest tools and treatment options in these ticketed, complimentary presentations. Learn More »

Product Forum**
Engage with medical industry representatives on your terms. Meet local contacts who understand that you don’t have time to talk with them at your practice.

 

Sessions & Syllabus

View the session schedule summary here.
Print Syllabus
Thursday, November 21, 2013
Friday, November 22, 2013
6:45 AM-7:30 AM
Registration and Breakfast
7:30 AM-7:45 AM
Opening Remarks
7:45 AM-8:15 AM
Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Complete all 6 sessions and you will receive REMS compliant training certificate. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA). This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies.

Learning Objectives:

  1. Identify risk factors for opioid-related aberrant behavior
  2. Differentiate between tolerance, physical dependence and addiction
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY
Michael J. Brennan MD, FACP, FASAM (Read Bio) Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT, Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Jeffrey Gudin MD (Read Bio) Director, Pain Management and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ
8:15 AM-8:45 AM
Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression.

Learning Objectives:

  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY
Michael J. Brennan MD, FACP, FASAM (Read Bio) Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT, Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Jeffrey Gudin MD (Read Bio) Director, Pain Management Center, Englewood Hospital and Medical Center, Englewood, NJ
8:45 AM-9:15 AM
Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment.

Learning Objectives:

  1. Evaluate and manage adverse effects of ER/LA-opioids
  2. Differentiate strategies for monitoring patient adherence
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY
Michael J. Brennan MD, FACP, FASAM (Read Bio) Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT, Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Jeffrey Gudin MD (Read Bio) Director, Pain Management and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ
9:15 AM-10:15 AM
Refreshment Break and Additional Opportunities
10:15 AM-11:00 AM
Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose.

Learning Objectives:

  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Michael J. Brennan MD, FACP, FASAM (Read Bio) Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT, Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Jeffrey Gudin MD (Read Bio) Director, Pain Management and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ
11:00 AM-11:30 AM
Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment.

Learning Objectives:

  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing
Charles Argoff MDAssistant Professor of Neurology, New York University School of Medicine, New York, NY, Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY
Michael J. Brennan MD, FACP, FASAM (Read Bio) Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT, Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT, Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT
Jeffrey Gudin MD (Read Bio) Director, Pain Management and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ
11:30 AM-12:15 AM
Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients

Learning Objectives:

  1. Differentiate the prescribing information among available ER/LA opioids
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only
Charles Argoff MD
Michael J. Brennan MD, FACP, FASAM (Read Bio)
Jeffrey Gudin MD (Read Bio)
12:15 PM-1:15 PM
Lunch Break and Additional Opportunities
1:15 PM-2:15 PM
Lung Sounds: A Primer on Pulmonary Auscultation
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.

Learning Objectives:

  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Salvatore Mangione MD (Read Bio) Associate Professor of Medicine, Jefferson Medical College, Philadelphia, PA
2:15 PM-3:15 PM
The Problem Pests: Ticks, Mites, Bed Bugs, and Lice
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.

Learning Objectives:

  1. Consider the manifestations of Lyme disease and testing interpretation in order to appropriately manage patients with suspected infection
  2. Identify body lice and educate patients and families about treatment and infestation prevention
Stephen Gluckman MD (Read Bio) Professor of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Medical Director, Penn Global Medicine, Philadelphia, PA
3:15 PM-4:15 PM
Refreshment Break and Additional Opportunities
4:15 PM-5:30 PM
Targeting Better Cardiac Outcomes for High-Risk Patients
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.

Learning Objectives:

  1. Evaluate recent clinical trials with respect to management of low HDL
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension
Danielle Duffy FACC, MD (Read Bio) Assistant Professor of Medicine, Division of Cardiology, Jefferson Medical College, Philadelphia, PA, Director, Cardiovascular Risk Reduction, Jefferson Heart Institute, Philadelphia, PA
Saturday, November 23, 2013

Ticketed Events

View Schedule for:

Morning Break

Non-CME Presentation Theater

9:25 AM-10:10 AM

Acute Coronary Syndrome

9:25 AM-10:10 AM

Pneumococcal Disease in Adults 50+

Lunch Break

Non-CME Presentation Theater

12:25 PM-1:10 PM

Alzheimer’s Disease

12:25 PM-1:10 PM

Ankylosing Spondylitis

Afternoon Break

Non-CME Presentation Theater

3:25 PM-4:10 PM

Atrial Fibrillation / Stroke

3:25 PM-4:10 PM

Depression

CLOSE  X  
Current Management Strategies in the Treatment of Acute Coronary Syndrome
Faculty:
  1. Bruce Decter, MD , FACC , FACP
CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Your Patients Aged 50+
Brought to you by: Pfizer Inc..
Faculty:
  1. Martin Mahoney, MD, PhD, FAAFP
CLOSE  X  
A Different Approach to Alzheimer's Disease: Axona® as an Alternate Fuel for the Brain
Brought to you by: Accera, Inc..
An Alzheimers disease (AD) patient brain is not able to utilize glucose as efficiently as a healthy patient. Ketones provide an alternate source of energy for the AD patient. Axona® supplies ketones to the brain to help improve memory and cognition.
Faculty:
  1. Paul Kostoulakos, DO
CLOSE  X  
Inflammatory Back Pain Recognition and Diagnosis
Brought to you by: AbbVie.
Faculty:
  1. Max Hamburger, MD
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Brought to you by: Janssen Pharmaceuticals, Inc..
CLOSE  X  
Discussion of a Treatment Option for Major Depressive Disorder
Faculty:
  1. Brendan Montano, MD

Accreditation

These educational programs are conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Primary Care Updates—Track One
November 21, 2013
Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
5.25 AAFP This live activity, Primary Care Updates Track 1, with a start date of 11/21/2013, has been reviewed and is acceptable for up to 5.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education
Primary Care Updates—Track Two
November 21, 2013
Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AAFP This live activity, Primary Care Updates Track 2, with a start date of 11/21/2013, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education
Regional Conference
November 22, 2013
Credits Type Accreditation Statement Designation Statement
6.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AAFP This live activity, Regional Conference New York, NY, with a beginning date of 11/22/2013, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.75 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 6.75 contact hours of continuing education (which includes 3.375 hours of pharmacology).
Primary Care Updates
November 23, 2013
Credits Type Accreditation Statement Designation Statement
4.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
4.5 AAFP This live activity, Primary Care Updates, with a begin date of 11/23/2013, has been reviewed and is acceptable for up to 4.5 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Integrated Approaches to Cardiometabolic Care
November 23, 2013
Credits Type Accreditation Statement Designation Statement
4.75 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
4.75 AAFP This live activity, Integrated Approaches to Cardiometabolic Care, with a begin date of 11/23/2013, has been reviewed and is acceptable for up to 4.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Robert Tanenberg, MD, FACP

Professor of Medicine, Division of Endocrinology, Medical Director, Inpatient Diabetes Program, Vidant Medical Center, East Carolina University, Greenville, NC
Medical Director, East Carolina University Diabetes and Obesity Institute, Greenville, NC

Presenting on:

  • Complementary Therapies to Improve Glucose Control in Type 2 Diabetes Role of GLP-1 Receptor Agonists & Basal Insulin
    Thursday, November 21, 2013, 7:45 AM-9:15 AM

Dace Trence, MD, FACE

Director, Diabetes Care Center, Professor, Division of Metabolism, Endocrinology and Nutrition, University of Washington Medical Center, Seattle, WA

Presenting on:

  • Complementary Therapies to Improve Glucose Control in Type 2 Diabetes Role of GLP-1 Receptor Agonists & Basal Insulin
    Thursday, November 21, 2013, 7:45 AM-9:15 AM

Stephen Brunton, MD, FAAFP

Executive Vice President for Education, Primary Care Education Consortium, Charlotte, NC

Presenting on:

  • Improving Treatment Adherence in Chronic Illness: Simple Evidence-Based Strategies for Use in Daily Practice
    Thursday, November 21, 2013, 7:45 AM-9:00 AM

Katherine Krauskopf, MD

Assistant Professor of Medicine, General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

Presenting on:

  • Improving Treatment Adherence in Chronic Illness: Simple Evidence-Based Strategies for Use in Daily Practice
    Thursday, November 21, 2013, 7:45 AM-9:00 AM

Ian Kronish, MD, MPH

Assistant Professor, Division of General Medicine, Columbia University Medical Center, New York, NY

Presenting on:

  • Improving Treatment Adherence in Chronic Illness: Simple Evidence-Based Strategies for Use in Daily Practice
    Thursday, November 21, 2013, 7:45 AM-9:00 AM

Holly Wyatt, MD (Read Bio)

Associate Professor of Medicine, Division of Endocrine, Metabolism, and Diabetes, Associate Director, Anschutz Health and Wellness Center, University of Colorado Denver, Denver, CO

Presenting on:

  • Breakthroughs in New Treatment Options for Obese Patients with Comorbidities
    Thursday, November 21, 2013, 9:15 AM-10:45 AM

Caroline Apovian, MD

Professor of Medicine and Pediatrics, Boston University School of Medicine, Boston, MA

Presenting on:

  • Breakthroughs in New Treatment Options for Obese Patients with Comorbidities
    Thursday, November 21, 2013, 9:15 AM-10:45 AM

Louis Aronne, MD, FACP (Read Bio)

Weill Professor of Metabolic Research, Medical Director, Center for Weight Management and Metabolic Clinical Research, Weill Cornell Medical College, New York, NY

Presenting on:

  • Breakthroughs in New Treatment Options for Obese Patients with Comorbidities
    Thursday, November 21, 2013, 9:15 AM-10:45 AM

JoAnne Foody, MD, FACC, FAHA (Read Bio)

Executive Director, Linda Joy Pollin Women’s Heart Center, Brigham and Women's Hospital, Boston, MA
Associate Professor of Medicine, Harvard Medical School, Boston, MA

Presenting on:

Michael Miller, MD, FACC, FAHA (Read Bio)

Professor, Departments of Medicine, Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD
Director, Center for Preventive Cardiology, University of Maryland Medical Center, Baltimore, MD

Presenting on:

  • Tackling the Toughest Issues and Cases of Hypertriglyceridemia
    Thursday, November 21, 2013, 9:30 AM-10:45 AM

Donna Ryan, MD (Read Bio)

Professor Emerita, Pennington Biomedical Research Center, Baton Rouge, LA

Presenting on:

  • Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
    Thursday, November 21, 2013, 10:45 AM-12:00 PM

Timothy Church, MD, MPH, PhD (Read Bio)

Professor and Director, Laboratory of Preventive Medicine, Pennington Biomedical Research Center, Baton Rouge, LA

Presenting on:

  • Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
    Thursday, November 21, 2013, 10:45 AM-12:00 PM

Kevin Oeffinger, MD (Read Bio)

Dir., Living Beyond Cancer: A Program for Adult Survivors of Pediatric Cancer, Departments of Pediatrics and Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Presenting on:

Lawrence Blonde, MD, FACP, FACE (Read Bio)

Director, Ochsner Diabetes Clinical Research Unit, Department of Endocrinology, Diabetes and Metabolism, Associate Director, Internal Medicine Residency Program, Ochsner Medical Center, New Orleans, LA

Presenting on:

Thomas Repas, DO, FACP, FACE, CDE, FNLA, FACOI

Clinical Associate Professor, Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Rapid City, SD

Presenting on:

Jane Seley, MPH, BC-ADM, CDE

Diabetes Nurse Practitioner, Division of Endocrinology, New York Presbyterian Hospital - Weill Cornell Medical Center, New York, NY

Presenting on:

Mark Avdalovic, MD, MAS, FCCP (Read Bio)

Associate Professor of Clinical Medicine, Division of Pulmonary and Critical Care Medicine, UC Davis School of Medicine, Redding, CA

Presenting on:

  • Evolving Therapeutic Approaches in the Clinical Management of COPD
    Thursday, November 21, 2013, 12:30 PM-1:45 PM

Raul Mendoza, MD, FCCP (Read Bio)

Pulmonary Physician, Aurora Medical Group, Green Bay, WI
Clinical Assistant Professor, University of Wisconsin School of Medicine, Madison, WI

Presenting on:

  • Evolving Therapeutic Approaches in the Clinical Management of COPD
    Thursday, November 21, 2013, 12:30 PM-1:45 PM

Stephen Rennard, MD (Read Bio)

Larson Professor of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Presenting on:

  • Clarifying the Confusion of COPD: Implementing Guidelines and Good Practice
    Thursday, November 21, 2013, 1:55 PM-3:10 PM

Fernando Martinez, MD, MS

Professor of Internal Medicine, Medical Director, Pulmonary Diagnostic Services, Associate Chief of Clinical Research, Co-Medical Director, Lung Transplantation, Division of Pulmonary & Critical Care, University of Michigan Health System, Ann Arbor, MI

Presenting on:

  • Clarifying the Confusion of COPD: Implementing Guidelines and Good Practice
    Thursday, November 21, 2013, 1:55 PM-3:10 PM

Javier Morales, MD (Read Bio)

Vice President, Principal Clinical Trails Investigator, Advanced Internal Medicine Group, New Hyde Park, NY

Presenting on:

  • Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care
    Thursday, November 21, 2013, 2:00 PM-3:30 PM

Jack Leahy, MD (Read Bio)

Chief, Division of Endocrinology, Diabetes and Metabolism, University of Vermont, Burlington, VT

Presenting on:

  • Incretin-Based Therapies for Type 2 Diabetes: Mechanism-Based Strategies to Achieve Patient-Centered Care
    Thursday, November 21, 2013, 2:00 PM-3:30 PM

Charles Argoff, MD

Assistant Professor of Neurology, New York University School of Medicine, New York, NY
Director, Cohn Pain Management Center, North Shore Long Island Jewish Health System, Valley Stream, NY

Presenting on:

Michael Brennan, MD, FACP, FASAM (Read Bio)

Medical Director, MD, The Pain Center of Fairfield, Fairfield, CT
Assistant Clinical Attending Physician, St. Vincent's Hospital, Bridgeport, CT
Private Practice, Physical Medicine and Rehabilitation, Senior Attending Physician, Department of Medicine, Section Pain Management & Rehabilitation, Bridgeport Hospital, Bridgeport, CT

Presenting on:

Jeffrey Gudin, MD (Read Bio)

Director, Pain Management and Palliative Care, Englewood Hospital and Medical Center, Englewood, NJ

Presenting on:

Salvatore Mangione, MD (Read Bio)

Associate Professor of Medicine, Jefferson Medical College, Philadelphia, PA

Presenting on:

Stephen Gluckman, MD (Read Bio)

Professor of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Medical Director, Penn Global Medicine, Philadelphia, PA

Presenting on:

Danielle Duffy, FACC, MD (Read Bio)

Assistant Professor of Medicine, Division of Cardiology, Jefferson Medical College, Philadelphia, PA
Director, Cardiovascular Risk Reduction, Jefferson Heart Institute, Philadelphia, PA

Presenting on:

Pamela Kushner, MA, MD, FAAFP (Read Bio)

Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA

Presenting on:

James Underberg, MD, FASH, FNLA, FACPM, MS, FACP (Read Bio)

Presenting on:

Robert Gleeson, MD, FACP, FNLA

Presenting on:

  • Managing Hypertension and Obesity through Therapeutics and Lifestyle Modifications
    Saturday, November 23, 2013, 9:15 AM-10:45 AM

Alan Brown, MD, FACC, FNLA (Read Bio)

Presenting on:

  • New Advancements in Managing the Patient with Severe Dyslipidemia
    Saturday, November 23, 2013, 11:00 AM-12:30 PM

Joseph Saseen, PharmD, FCCP, BCPS

Presenting on:

  • New Advancements in Managing the Patient with Severe Dyslipidemia
    Saturday, November 23, 2013, 11:00 AM-12:30 PM

Yehuda Handelsman, FNLA, MD, FACP, FACE (Read Bio)

Private Practice, Endocrinologist, Tarzana, CA
Medical Director & Principal Investigator, Metabolic Institute of America, Tarzana, CA

Presenting on:

Peter Libby, FACC, MD (Read Bio)

Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA
Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA

Presenting on:

Paul Rosenblit, MD, PhD, FACE, FNLA (Read Bio)

Clinical Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of California, Irvine, Irvine, CA
Co-Director, Diabetes Out-Patient Clinic, UC Irvine Medical Center, Orange, CA

Presenting on:

Course Directors

Clyde W. Yancy, MD, MSc, FACC, FAHA, MACP

  • Magerstadt Professor of Medicine, Chief, Division of Cardiology, Northwestern University Feinberg School of Medicine
  • John J. Russell, MD

  • Clinical Professor, Family and Community Medicine, Temple University School of Medicine
  • Associate Director, Family Medicine Residency Program, Abington Memorial Hospital
  • William D. Chey, MD, AGAF, FACG, FACP

  • Professor of Medicine, Director, GI Physiology Laboratory, Co-Director, Michigan Bowel Control Program, H. Marvin Pollard Institute Scholar, Division of Gastroenterology, University of Michigan Health System
  • M. Susan Burke, MD, FACP

  • Adjunct Associate Professor of Geriatrics, Philadelphia College of Osteopathic Medicine
  • Senior Advisor, Lankenau Medical Associates, Lankenau Medical Center
  • Silvio E. Inzucchi, MD

  • Professor of Medicine, Yale University School of Medicine
  • Clinical Chief, Endocrinology, Yale-New Haven Hospital
  • Neil Skolnik, MD

  • Professor, Family and Community Medicine, Temple University School of Medicine
  • Associate Director, Family Medicine Residency Program, Abington Memorial Hospital
  • Scott C. Litin, MD, MACP

  • Professor of Medicine, Division of General Internal Medicine, Mayo Clinic College of Medicine
  • James V. Hennessey, MD, FACP

  • Associate Professor of Medicine, Harvard Medical School
  • Director, Clinical Endocrinology, Beth Isreal Deaconess Medical Center
  • Mark Zimmerman, MD

  • Professor of Psychiatry and Human Behavior, Brown Medical School
  • Director of Outpatient Psychiatry, Rhode Island Hospital, The Miriam Hospital
  • F. Wilford Germino, MD, FACP, FASH

  • Assistant Professor, Department of Internal Medicine, Rush Medical College
  • , Department of Internal Medicine, Orland Primary Care Specialists
  • Kalpana Gupta, MD, MPH

  • Associate Professor of Medicine, Boston University School of Medicine
  • Adelaide Hebert, MD

  • Professor of Dermatology and Pediatrics, University of Texas Medical School
  • John B. Bundrick, MD

  • Assistant Professor of Medicine, Mayo Clinic College of Medicine
  • Consultant in Medicine, Mayo Clinic
  • Beth L. Jonas, MD

  • Associate Professor of Medicine, Department of Medicine/Division of Rheumatology, Director, Rheumatology Fellowship Training Program, University of North Carolina School of Medicine
  • Sheila Eileen Crowe, MD, FRCPC, FACP, FACG, AGAF

    Start:  End: 
    Expand Expand Instructions Print PrintMap

    Travel Arrangements

    Meeting Location

    Jacob K. Javits Convention Center
    655 W 34th St
    New York, NY 10001-1197
    (212) 216-2000

    Hotel Accommodations

    Company
    Exhibitors
    Support
    Terms
    Tel: (877) 477-4633